A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer (Q72653930)
Jump to navigation
Jump to search
scientific article published on 01 December 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer |
scientific article published on 01 December 1994 |
Statements
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer (English)
P Lissoni
S Meregalli
V Fossati
F Paolorossi
S Barni
G Tancini
1 December 1994